Clinical Trials Directory

Trials / Completed

CompletedNCT02594644

The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
University of California, Davis · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to investigate how varying incubation periods of topical aminolevulinic acid after pretreatment with microneedle application can facilitate the penetration and efficacy of photodynamic therapy.

Detailed description

The current standard of care of photodynamic therapy to treat actinic keratoses includes pre-treatment of the area with topical aminolevulinic acid for 1 hour, followed by treatment with blue light. In a previous study, the investigators showed pretreatment of microneedles enhance penetration of topical aminolevulinic acid as compared to the control group. The aim of this study is to investigate how varying incubation periods of topical aminolevulinic acid after pretreatment with microneedle application can facilitate the penetration and efficacy of photodynamic therapy.

Conditions

Interventions

TypeNameDescription
DEVICEMicroneedle RollerThe study device (MR200, Clinical Resolutions Laboratory, Inc.) is a disposable roller equipped with stainless steel needles that are 650 micrometers in length.
DRUGAminolevulinic AcidLevulan® Kerastick® DUSA Pharmaceuticals, Inc., Wilmington, MA
RADIATIONBlue LightBlu-U unit (DUSA Pharmaceuticals, Inc., Wilmington, MA

Timeline

Start date
2014-11-06
Primary completion
2016-06-22
Completion
2016-06-22
First posted
2015-11-03
Last updated
2018-11-29
Results posted
2018-11-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02594644. Inclusion in this directory is not an endorsement.